(Press-News.org) Oak Brook, IL (USA) — The Society for Laboratory Automation and Screening (SLAS) has been awarded a $199,884 grant from the Alfred P. Sloan Foundation to lead a multi-year initiative to develop education standards for laboratory automation, addressing a growing gap between the rapid adoption of automation technologies and formal training pathways for the scientific workforce.
The project, Standards for Automated Science Education, will establish evidence-based, interdisciplinary guidelines to help educators prepare students for the technical competencies required in modern laboratory environments. The work will be led by Kennedy McDaniel Bae, PhD, in collaboration with Joshua D. Kangas, PhD, associate teaching professor at Carnegie Mellon University, and a diverse expert drafting committee drawn from academia, industry and professional networks including SLAS, the Acceleration Consortium (University of Toronto) and others.
Laboratory automation increasingly integrates robotics, machine learning and artificial intelligence across pharmaceutical, biotechnology, manufacturing and academic research settings. Despite this growth, automation training is often fragmented and institution-specific, creating challenges for educators and employers alike.
“The automation infrastructure investments have been massive, but training infrastructure hasn't kept pace,” says Bae. “We're building that missing piece—the first comprehensive framework that bridges traditional education with the convergence of robotics, AI, and machine learning.”
The project includes four primary components: assessing industry workforce needs and educational barriers; developing tiered competency standards aligned with real-world job requirements; curating and publishing implementation-ready teaching resources; and documenting broader insights on successful models for integrating automation into curricula. All guidelines and resources will be made openly available under a Creative Commons license and hosted long-term by SLAS.
“SLAS is committed to strengthening the scientific workforce by connecting education, technology and real-world application,” said Vicki Loise, CMP, CAE, chief executive officer of SLAS. “This project directly supports that mission by creating shared standards that help educators, employers and learners speak the same language—ultimately accelerating innovation across the life sciences.”
Padraic Foley, Director, Strategy and Partnerships at the Acceleration Consortium (University of Toronto) and member of the Standards Drafting Committee, affirmed the initiative, "To fully realize the potential of autonomous science, we need a workforce skilled not just in biology or chemistry, but in the integration of robotics and data. This initiative is a critical step toward upskilling researchers and creating a shared language that connects education with industry needs."
By creating a common framework and language for automation education, the project is expected to reduce hiring friction, expand access to automation training across institution types, and strengthen workforce pipelines in data-driven and automated science.
The guidelines and accompanying resources are scheduled for public release beginning in late 2026, with broader findings and publications extending into 2027.
* * * *
SLAS (Society for Laboratory Automation and Screening) is an international professional society of academic, industry and government life sciences researchers and the developers and providers of laboratory automation technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.
SLAS publishes two peer-reviewed and MEDLINE-indexed scientific journals, SLAS Discovery and SLAS Technology. For more information about SLAS and its journals, visit www.slas.org/journals.
The Alfred P. Sloan Foundation is a not-for-profit, mission-driven grantmaking institution dedicated to improving the welfare of all through the advancement of scientific knowledge. Established in 1934 by Alfred Pritchard Sloan Jr., then-President and Chief Executive Officer of the General Motors Corporation, the Foundation makes grants in four broad areas: direct support of research in science, technology, engineering, mathematics, and economics; initiatives to increase access and opportunity in graduate science education; projects to develop or leverage technology to empower research; and efforts to enhance and deepen public engagement with science and scientists. sloan.org | @SloanFoundation
###
END
Background and Aims
Infections are frequent and lethal complications of acute-on-chronic liver failure (ACLF). Reliable biomarkers to distinguish fungal from bacterial infections remain limited. Given the central role of immune dysfunction in ACLF, we aimed to evaluate the diagnostic value of serum cytokines in differentiating invasive pulmonary aspergillosis (IPA) from bacterial pneumonia (BP) in HBV-associated ACLF.
Methods
This retrospective case-control study enrolled ACLF patients admitted to the Tongji Hospital, between 2018 and 2022. Patients were categorized into IPA, BP, and non-infection groups. The BP and non-infection groups were propensity score-matched ...
Desire on the Couch is a thought-provoking exhibition coming to San Francisco January 28th. Co-organized by the California Institute of Integral Studies (CIIS) and the Kinsey Institute, the exhibition traces a century-long struggle over how sexuality is measured, medicalized, and experienced. Visitors are invited to explore rarely-seen letters, photographs, and archival materials that reveal how ideas about sexuality and desire have long been argued over, resisted, and reimagined.
“Sexuality is an important topic because the way in which ...
Doctors may soon be able to tell just how sick a heart failure patient really is by using a routine MRI scan, thanks to new research from the University of East Anglia.
People with heart failure often need a test called right heart catheterisation, where a tube is inserted into the heart to measure oxygen levels in the blood. This helps doctors understand how severe the condition is.
But the invasive procedure is far from pleasant and carries risks, especially for older, frail or unwell patients.
In collaboration with researchers at the University of Leeds and Newcastle University, the team developed a way to estimate ...
The Kraft Center for Community Health at Mass General Brigham today announced the launch of the second annual Kraft Prize for Excellence and Innovation in Community Health, a national award recognizing organizations and innovators driving measurable improvements in community health with scalable, real-world models.
The prize will award $100,000 to one recipient addressing critical health challenges in any of a number of areas — cancer, cardiometabolic disease, substance use disorder, maternal health, ...
Highlights:
Pneumocystis fungi are difficult to study and culture, making it difficult to develop new treatments.
The fungi are thought to use extracellular vesicles (EVs) to scavenge nutrients from the environment.
Researchers have harnessed EVs to deliver CRISPR-Cas9 gene-editing technology inside the fungus.
Tests on mice showed that the method worked to modify genes in the fungus associated with treatment resistance.
Washington, D.C.—Pneumocystis is an unwieldy genus of fungal pathogens that cause severe pneumonia, particularly in immunocompromised people like those with HIV/AIDs ...
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a highly prevalent chronic liver condition globally, with its management spanning risk assessment, early diagnosis, staged intervention, and long-term follow-up. The integration of artificial intelligence (AI) and smart devices offers innovative approaches to address challenges in precision diagnosis and personalized treatment. This review synthesizes current applications of AI and smart devices across the MASLD care continuum, discusses their benefits and limitations, and outlines future directions to advance precision hepatology.
Introduction
MASLD, characterized by hepatic lipid accumulation linked to metabolic ...
More than 135 million American adults are either living with or at risk for type 2 diabetes (T2D), elevating the need for more evidence-based dietary guidance to help this growing population achieve optimal health and reduce risks for T2D and its complications. Recently published findings from a randomized controlled trial (RCT) demonstrate that eating 6-7 ounces of beef per day does not impact risk factors for T2D, as well as other cardiometabolic health markers, in adults with prediabetes. The study, “Effects of Diets Containing Beef Compared with Poultry on Pancreatic β -Cell Function and Other Cardiometabolic Health Indicators in Males and ...
Penn Engineers have developed a novel design for solar-powered data centers that will orbit the earth and could realistically scale to meet the growing demand for AI computing while reducing the environmental impact of data centers.
Reminiscent of a leafy plant, with multiple, hardware-containing stems connected to branching, leaf-like solar panels, the design leverages decades of research on “tethers,” rope-like cables that naturally orient themselves under the competing forces of gravity and centrifugal motion. This architecture could ...
To support research that could lead to significant external funding, Binghamton University’s Thomas J. Watson College of Engineering and Applied Science has established a new program offering seed grants to faculty members working in key topic areas.
The Watson College Seed Grant Program for Major Research Proposal Development is designed as a catalyst for accelerating interdisciplinary research, addressing pressing scientific and technological challenges while demonstrating a path to major research funding from external sponsors.
Six projects will receive $160,000 in ...
Cancer immunotherapy has transformed modern oncology by harnessing body’s own immune system to combat malignant disease. Immune checkpoint inhibitors targeting the PD-1/PD-L1 pathway have produced durable responses in a subset of patients, raising hopes for long-term cancer control. However, for most patients, these therapies offer limited benefit, as tumors evolve mechanisms to evade immune surveillance. This limitation has shifted research focus toward the molecular basis of immune resistance, particularly strategies that suppress immune function beyond the local tumor microenvironment. ...
